Arcturus obtains approval for Phase IIIb Covid vaccine trial in Vietnam
The trial will have nearly 20,000 subjects, who will receive two doses of the vaccine 28 days apart or a…

The trial will have nearly 20,000 subjects, who will receive two doses of the vaccine 28 days apart or a…
The Phase I/II/III trial will enrol up to 21,000 adults to evaluate the safety, immunogenicity and efficacy of the mRNA…
Thank you for subscribing to Clinical Trials Arena